Predicting Effectiveness of Light Treatment for Winter Seasonal Affective Disorder
Predicting Light Treatment's Effectiveness on Reducing Depression and Cardiovascular Risk in Seasonal Affective Disorder
4 other identifiers
observational
41
0 countries
N/A
Brief Summary
This study will evaluate a possible tool for predicting future effectiveness of bright light in treating seasonal affective disorder, winter subtype, and will examine secondary effects of bright light on cardiovascular risk factors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2007
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 25, 2008
CompletedFirst Posted
Study publicly available on registry
August 27, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedNovember 21, 2019
November 1, 2019
2.4 years
August 25, 2008
November 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hamilton rating scale for depressional seasonal affective disorder (SIGH SAD)
Measured at baseline, 1 hour after light treatment, and weekly for 6 weeks
Secondary Outcomes (8)
Hunger questionnaire
Measured daily for 6 weeks
Three factor eating questionnaire
Measured weekly for 6 weeks
Sleep log
Measured weekly for 6 weeks
Food craving questionnaire
Measured daily for 6 weeks
Side effects questionnaire
Measured weekly for 6 weeks
- +3 more secondary outcomes
Study Arms (2)
A
Participants will be given a 1-hour lab test of bright light treatment, then the bright light treatment for 6 weeks.
B
Participants will be given a 1-hour treatment of the red light placebo, then the bright light treatment for 6 weeks.
Interventions
One hour of exposure to bright light daily upon awakening for 6 weeks.
One hour of exposure to red light.
Eligibility Criteria
Patients with history of recurrent winter depression
You may qualify if:
- Current major depressive disorder, by structured diagnostic interview (SCID), or current bipolar II disorder, if no prior history of rapid cycling, by SCID
- Prior history of major depressive disorder or bipolar II disorder with seasonal specifier, by SCID
- Score of 21 or greater on Hamilton Rating Scale for Depression - Seasonal Affective Disorder Version (SIGH-SAD), met at three time points (informed consent session, 24 hours prior to first light therapy session, and at first light therapy session)
You may not qualify if:
- Current bipolar I disorder, psychotic disorder, or cognitive disorder, by SCID
- Illicit drug use in the past year, by self-report, or alcohol abuse by SCID
- History of systemic lupus erythematosus
- History of heart attack or stroke
- No antidepressant, mood stabilizer, or antipsychotic medication treatment 30 days before treatment
- Current occupation involves shift work
- Current sensitivity to bright light or vision problems not correctable by glasses, by self-report
- Inability to distinguish colors or see stars at night because of increased light sensitivity, by self-report
- Current suicidal ideation, by self-report during SCID interview
- Women of childbearing potential who are pregnant, nursing, or trying to become pregnant. Female participants of childbearing potential must agree to one of the following types of birth control: oral, transdermal, or implantable hormonal contraceptives; intrauterine device; diaphragm plus spermicide; or female condom plus spermicide.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Uzoma HN, Reeves GM, Langenberg P, Khabazghazvini B, Balis TG, Johnson MA, Sleemi A, Scrandis DA, Zimmerman SA, Vaswani D, Nijjar GV, Cabassa J, Lapidus M, Rohan KJ, Postolache TT. Light treatment for seasonal Winter depression in African-American vs Caucasian outpatients. World J Psychiatry. 2015 Mar 22;5(1):138-46. doi: 10.5498/wjp.v5.i1.138.
PMID: 25815263BACKGROUNDReeves GM, Rohan KJ, Langenberg P, Snitker S, Postolache TT. Calibration of response and remission cut-points on the Beck Depression Inventory-Second Edition for monitoring seasonal affective disorder treatment outcomes. J Affect Disord. 2012 Apr;138(1-2):123-7. doi: 10.1016/j.jad.2011.12.003. Epub 2012 Jan 25.
PMID: 22277151BACKGROUNDReeves GM, Nijjar GV, Langenberg P, Johnson MA, Khabazghazvini B, Sleemi A, Vaswani D, Lapidus M, Manalai P, Tariq M, Acharya M, Cabassa J, Snitker S, Postolache TT. Improvement in depression scores after 1 hour of light therapy treatment in patients with seasonal affective disorder. J Nerv Ment Dis. 2012 Jan;200(1):51-5. doi: 10.1097/NMD.0b013e31823e56ca.
PMID: 22210362BACKGROUNDVirk G, Reeves G, Rosenthal NE, Sher L, Postolache TT. Short exposure to light treatment improves depression scores in patients with seasonal affective disorder: A brief report. Int J Disabil Hum Dev. 2009 Jul;8(3):283-286. doi: 10.1901/jaba.2009.8-283.
PMID: 20686638BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Teodor T. Postolache, MD
University of Maryland, Baltimore
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 25, 2008
First Posted
August 27, 2008
Study Start
November 1, 2007
Primary Completion
April 1, 2010
Study Completion
August 1, 2010
Last Updated
November 21, 2019
Record last verified: 2019-11